#17 What role will GPT-3 play in the longevity sector?
The most exciting AI technology to emerge from 2022 is likely to play an outsized role in healthcare
The Agenda 👇
News bulletin 📰
What role will GPT-3 play in the longevity sector?
Recent funding in longevity 💰
Upcoming events 📅
Jobs in longevity 🧑💼
1/ News bulletin 📰
🧠 OpenAI’s GPT-3 program can identify clues from spontaneous speech that are 80% accurate in predicting the early stages of dementia - according to new research from Drexel University
💊 Capsida Biotherapeutics announces a $55m strategic collaboration with Prevail Therapeutics - an Eli Lilly company, to develop transformative genetic medicines
🧠 Gero entered into a research collaboration with Pfizer - to apply Gero’s AI platform to discover therapeutic targets for fibrotic diseases
⏰ New research discovers a quality control mechanism that regulates ageing and fertility - the work from IMBB is published in Nature Ageing
🏥 Four new genetic loci that partially explain extreme longevity - are identified in a study published in International Journal of Molecular Sciences
2/ What role will GPT-3 play in the longevity sector?
Generative Pre-Text Transformer 3 (GPT-3) is the great AI technology tool to emerge from 2022, developed by OpenAI. It is a language model that uses machine learning algorithms to generate coherent and coherently formatted text based on a given input. GPT-3 has the ability to learn and adapt to new data and can generate human-like text, making it a useful tool for various applications, including the advance of the longevity industry.
One of the leading ways that GPT-3 can help increase the human lifespan is through its ability to assist in the early detection and diagnosis of diseases. GPT-3 can analyse medical records and other data, such as test results and patient history, to identify patterns and correlations that may indicate the presence of a particular disease. This can help doctors and other healthcare professionals to identify potential health issues at an early stage, allowing for prompt treatment and the prevention of further deterioration. Recent research from Drexel University has already shown that OpenAI’s GPT-3 program can identify clues from spontaneous speech that are 80% accurate in predicting the early stages of dementia.
This is in additional to the role GPT-3 can play in the optimisation of existing treatments and therapies. By analysing the data of patients who have undergone various treatments, GPT-3 can identify factors that may influence the effectiveness of a particular therapy. This can help doctors to tailor treatments to the individual needs of their patients, increasing the chances of success and potentially increasing the lifespan of patients.
GPT-3 can also help in the development of new treatments and therapies for various diseases. By analysing large amounts of medical data, GPT-3 can identify potential targets for drug development and suggest new treatment options based on the data it has analysed. This can help researchers to develop more effective treatments for diseases that may have previously been considered incurable or difficult to treat.
Another way that GPT-3 can help increase the human lifespan is through its ability to assist in the development of new technologies and innovations that can improve the quality of life. GPT-3 can analyse data from various sources, including scientific research and industry trends, to identify areas where new technologies or innovations can be developed. This can help to address issues that may be limiting the human lifespan, such as environmental pollution or the lack of access to clean water and food.
In summary, GPT-3 has the potential to play a significant role in increasing the human lifespan through its ability to assist in the early detection and diagnosis of diseases, the development of new treatments and therapies, the optimization of existing treatments and therapies, and the development and optimization of technologies and innovations that can improve the quality of life. By leveraging the power of GPT-3, we can work towards a future where people live longer, healthier, and more fulfilling lives.
3/ Recent funding in longevity 💰
4/ Upcoming events 📅
🇺🇸 VitaDAO Hackathon, powered by LongHack is taking place on January 20-22. It is a virtual forum for innovators to present ideas and solutions for behavioural health and wellness. Studies have shown that people who engage in healthier behaviors and have access to the latest health solutions live longer, more productive lives.Join the VitaDAO Hackathon to discuss the future of healthcare.
🇵🇹 Longevity Med Summit will focus on the development of ageing science, regenerative medicine, and longevity therapeutics. This two-day summit will take place in Lisbon, Portugal on May 4 - May 5, 2023 and feature five themes: Longevity Therapeutics, P4 Medicine, Diagnostics, AI and Digital, and a showcase of new trials and research.
5/ Jobs in longevity 🧑💼
Humacyte // Regulatory Affairs Manager // Durham, North Carolina
Gameto // Research Embryologist // Madrid, Spain
Elysium Health // Director of Scientific Affairs // New York, NY
Altos Labs // US general interest - UK general interest // US - UK
Insilico Medicine // Business Development Consultant // Europe, Remote